Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aurinia Pharm Ord (NQ: AUPH )

15.76 USD +0.31 (+2.01%)
Streaming Delayed Price Updated: 9:30 AM EST, Jan 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30,643
Open 15.78
Bid (Size) 15.76 (1)
Ask (Size) 15.85 (1)
Prev. Close 15.45
Today's Range 15.66 - 15.78
52wk Range 9.720 - 33.97
Shares Outstanding 128,395,927
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences
January 04, 2022
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences. 
From Business Wire News Releases
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
December 09, 2021
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced... 
From Business Wire News Releases

Performance

YTD
-29.89%
-29.89%
1 Month
-34.09%
-34.09%
3 Month
-48.07%
-48.07%
6 Month
+37.04%
+37.04%
1 Year
-15.86%
-15.86%

More News

Read More
AUPH Crosses Below Key Moving Average Level
January 21, 2022
Tags Stocks
From Market News Video
Expert Ratings For Aurinia Pharmaceuticals
December 10, 2021
Tags BZI/AAR Benzinga AUPH
From Benzinga
Aurinia's Voclosporin Shows favorable Risk/Benefit Profile Over 3 Years In Lupus Nephritis
December 09, 2021
Tags Phase 3 Trial AUPH News
From Benzinga
My 3 Top Biopharma Stock Picks for 2022
January 09, 2022
Tags Recent Press Releases CRDF PFE
From Motley Fool
ESML's Holdings Could Mean 22% Gain Potential
December 09, 2021
Tags ETFs
From ETF Channel
The 2 Nasdaq Biotech Stocks to Watch Thursday
December 09, 2021
Tags AUPH Market News ^IXIC
From Motley Fool
EXPR Stock: 7 Reasons Why Express Investors Are Feeling Giddy Today
December 02, 2021
Tags Today's Market BFRI NYSE:EXPR,NASDAQ:BFRI,NASDAQ:AUPH,NYSE:SQ
From InvestorPlace
8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022
December 07, 2021
Tags FOLD ADAP BBIO
From Motley Fool
BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today
December 02, 2021
Tags NASDAQ:BFRI,NASDAQ:AUPH,NYSE:SQ,NYSE:AI SQ Market News
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media